Last edition
News about "IND Clearance "
Life Biosciences Wins FDA IND Clearance for ER-100
The IND clearance allows Life Bio to initiate a clinical programme evaluating ER-100’s safety and potential to improve vision in patients with optic neuropathies.
IND Clearance | 29/01/2026 | By News Bureau | 1416
Ascletis Receives FDA IND Clearance for Phase II ASC30 Diabetes Study
Ascletis has received US FDA IND clearance to initiate a 13-week phase-II, randomised, double-blind, placebo-controlled, multi-centre study evaluating the efficacy, safety and tolerability of its oral small-molecule GLP-1 candidate ASC30 in participants with diabetes, with enrollment expected to begin in the first quarter of 2026.
IND Clearance | 05/01/2026 | By News Bureau
Grit Biotechnology Secures IND Clearance for GT201 from US FDA
GT201, an advanced genetically engineered TIL product developed by Grit Biotechnology's platforms StemTexp and StaViral, boosts T cell survival and function by expressing a vital membrane-bound cytokine complex.
IND Clearance | 02/09/2024 | By Aishwarya | 384
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy